Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 5/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL170423 | 1.00 | PTGS2 (0.50) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL28373276 | 0.98 | PTGS2 (0.49) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL11824904 | 0.83 | PTGS2 (0.48) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL2739332 | 0.82 | PTGS2 (0.74) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL11821456 | 0.82 | PTGS2 (0.74) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL4734664 | 0.81 | CYP17A1 (0.39) | PTGS2OPRK1PDE4DHPGDKMT2A | |
| SCHEMBL1345773 | 0.78 | MEN1 (0.38) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL31195717 | 0.77 | NOX1 (0.46) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL11824485 | 0.77 | PTGS2 (0.43) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL3850258 | 0.77 | ALDH1A1 (0.53) | PTGS2OPRK1PDE4DALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595370-B2 | Polymerizable absorbers of UV and high energy visible light | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| EP-4155354-B1 | INK COMPOSITION FOR PHOTOCURABLE INKJET PRINTING | SAKATA INX CORP (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-20260044018-A1 | MULTIFOCAL CONTACT LENS DISPLAYING IMPROVED VISION ATTRIBUTES | JOHNSON & JOHNSON VISION CARE (US) | 2026-02-12 | — | — | US | disclosed |
| US-12534623-B2 | Contact lens with improved tear film optical quality | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2026-01-27 | — | — | US | disclosed |
| US-12515470-B2 | UV-Vis radiation curable security inks | SICPA HOLDING SA (CH) | 2026-01-06 | — | — | US | disclosed |
| US-20260003209-A1 | TORIC CONTACT LENS DISPLAYING IMPROVED VISION ATTRIBUTES | JOHNSON & JOHNSON VISION CARE (US) | 2026-01-01 | — | — | US | disclosed |
| US-12503618-B2 | Photocurable inkjet printing ink composition | SAKATA INX CORPORATION (JP) | 2025-12-23 | — | — | US | disclosed |
| US-12486348-B2 | Contact lens displaying improved vision attributes | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2025-12-02 | — | — | US | disclosed |
| US-12481173-B2 | Multifocal contact lens displaying improved vision attributes | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2025-11-25 | — | — | US | disclosed |
| WO-2023233896-A1 | PHOTOSENSITIVE RESIN COMPOSITION | 東京応化工業株式会社 | 2023-12-07 | — | — | WO | disclosed |
| WO-2023233895-A1 | POLYIMIDE RESIN PRECURSOR | 東京応化工業株式会社 | 2023-12-07 | — | — | WO | disclosed |
| WO-2023176172-A1 | POLYIMIDE RESIN PRECURSOR | 東京応化工業株式会社 | 2023-09-21 | — | — | WO | disclosed |
| US-20230220225-A1 | PHOTOCURABLE INKJET PRINTING INK COMPOSITION | SAKATA INX CORPORATION (JP) | 2023-07-13 | — | — | US | disclosed |
| WO-2023058385-A1 | BLOCK COPOLYMER | 東京応化工業株式会社 | 2023-04-13 | — | — | WO | disclosed |
| EP-4155354-A1 | INK COMPOSITION FOR PHOTOCURABLE INKJET PRINTING | Sakata INX Corporation (JP) | 2023-03-29 | — | — | EP | disclosed |
| US-20230066936-A1 | CONTACT LENS WITH IMPROVED TEAR FILM OPTICAL QUALITY | JOHNSON & JOHNSON VISION CARE, INC. | 2023-03-02 | — | — | US | disclosed |
| US-11543683-B2 | Multifocal contact lens displaying improved vision attributes | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| US-20220340760-A1 | POLYMERIZABLE ABSORBERS OF UV AND HIGH ENERGY VISIBLE LIGHT | JOHNSON & JOHNSON VISION CARE, INC. | 2022-10-27 | — | — | US | disclosed |
| WO-2022138012-A1 | POLYMERIZABLE COMPOSITION AND MANUFACTURING METHOD FOR ELEMENT-MOUNTED SUBSTRATE | 東京応化工業株式会社 | 2022-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595370-B2 | Polymerizable absorbers of UV and high energy visible light | NLRP3, NLRP1, XDH | PTGS2 739/4885OPRK1 765/4885PDE4D 2155/4885 |
| US-20260044018-A1 | MULTIFOCAL CONTACT LENS DISPLAYING IMPROVED VISION ATTRIBUTES | NECTIN4, CRYAB, PSEN1 | PTGS2 2809/4885OPRK1 3558/4885PDE4D 3043/4885 |
| US-20260003209-A1 | TORIC CONTACT LENS DISPLAYING IMPROVED VISION ATTRIBUTES | TRPA1, LATS2, TEC | PTGS2 2313/4885OPRK1 3448/4885PDE4D 2717/4885 |
| US-12534623-B2 | Contact lens with improved tear film optical quality | CUTA, CRYAA, TCOF1 | PTGS2 645/4885OPRK1 3056/4885PDE4D 3003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.